Skip to main content
. 2022 Jun 6;20:255. doi: 10.1186/s12967-022-03468-7

Fig. 2.

Fig. 2

Expression and prognostic value analysis of RAF1 in clinical specimens. AB qRT-PCR and WB assay of RAF1. C Immunohistochemical staining for RAF1. D Kaplan–meier survival curve of of risk factor for lymphatic metastasis. E Kaplan–meier survival curve of of risk factor for RAF1 expression. L, lymphatic metastasis patients' tumor tissue; NL, non-lymphatic metastasis patients’ tumor tissue; N, Normal tissue adjacent to the carcinoma. **P < 0.01, ***P < 0.001